Brief: Genxone 4.3 Mln Zloty Offer Chosen As Most Favourable In Tender
March 6 (Reuters) - Genxone SA GX1.WA :
* IT'S 4.3 MILLION ZLOTY NET OFFER CHOSEN AS MOST FAVOURABLE
IN
TENDER BY HUMAN BIOME INSTITUTE
* OFFER FOR OXFORD NANOPORE TECHNOLOGIES BIOLOGICAL MATERIAL
NGS
SEQUENCING SERVICES
* COMPLETION DATE OF ENTIRE ORDER CANNOT EXCEED JUNE 12,
2029
Source text for Eikon: urn:newsml:reuters.com:*:nEM9g8xsma
Further company coverage: GX1.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Genxone SA
See all newsBrief: Genxone Q2 Net Loss 0.3 Million Zlotys
Brief: Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Brief: Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
Brief: Genxone Q1 Net Loss 0.5 Million Zlotys
Brief: Genxone FY Net Loss 2.6 Million Zlotys